Nuveen’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
FBIL
Nuveen's LEGN Position: Q1 2026 in Review
Nuveen increased its Legend Biotech (LEGN) stake by 2.3% in Q1 2026, buying an estimated $41.9K and bringing the position to 96,786 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2324.
Nuveen first reported a position in LEGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.54M in Q4 2023. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.
- Nuveen held 96,786 shares of Legend Biotech worth $1.75M as of Q1 2026.
- Nuveen bought 2,200 Legend Biotech shares in Q1 2026, an estimated $41.9K.
- Legend Biotech made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2324 holding.
- Nuveen first reported a position in Legend Biotech in Q4 2021 and has held it in 18 quarters since.
- Nuveen's Legend Biotech position peaked at $9.54M in Q4 2023.
- 191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.